Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranolazine for the Prevention of Recurrent Persistent Atrial Fibrillation After Electrical Cardioversion: A Pilot Study

NCT01349491 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT01349491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranolazine for the Prevention of Recurrent Persistent Atrial Fibrillation After Electrical Cardioversion: A Pilot Study
Lead sponsor
University of Oklahoma
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2012
Completion date
June 30, 2014
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation